²¹²Pb-DOTAM-GRPR1: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving ²¹²Pb-DOTAM-GRPR1

• Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
  NCT05283330 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations

Common questions

How many recruiting trials involve ²¹²Pb-DOTAM-GRPR1?

1 recruiting trial across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.